Ocular Therapeutix, Inc. Share Price

Ocular Therapeutix, Inc. Share Price

NASDAQ: OCUL | Small Cap
$6.01
+$0.02 (0.42%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Ocular Therapeutix, Inc. Stock Performance

Open
$5.97
Prev. Close
$5.99
Circuit Range
N/A
Day Range
$5.81 - $6.24
Year Range
$5.81 - $16.41
Volume
1,45,730
Average Traded
$6.00

Ocular Therapeutix, Inc. Share Price Today

As of 18 November 2026, Ocular Therapeutix, Inc.'s share price is $6.01. The stock opened at $5.97, compared to its previous close of $5.99. During today's trading session, Ocular Therapeutix, Inc.'s share price traded between $5.81 and $6.24, with an average price of $6.03. Over the past 52 weeks, the stock has recorded a high of $16.41 and a low of $5.81. In terms of performance, Ocular Therapeutix, Inc.'s share price has declined by 33.43% over the last six months and is down 50.47% on a year-on-year basis.

Ocular Therapeutix, Inc. Share Price Chart

Line chart of the Ocular Therapeutix, Inc. price trend over the selected period. The price rose overall, ranging from 5.81 to 6.23, ending at 6.01.
$5.81$6.24
L
Show Current Price
H

Ocular Therapeutix, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.13B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.49
Revenue (TTM)
$51.95B
Return On Equity (TTM)
-74.12%
Profit Margin
-511.92%
Debt to Equity
0.17
Quarterly Earnings Growth YoY
-46.60%

Ocular Therapeutix, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$13.25$10.79$13.48$12.87
Net Profit-$64.65-$88.61-$78.76-$94.78
Net Profit Margin-487.92%-821.22%-584.27%-736.44%
Income ChangeN/A-37.06%11.12%-20.34%

Ocular Therapeutix, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$51.49$58.44$63.72$51.95
Net Profit-$71.04-$80.74-$193.51-$265.94
Net Profit Margin-137.97%-138.16%-303.69%-511.92%
Income ChangeN/A-13.65%-139.67%-37.43%

About Ocular Therapeutix, Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Ocular Therapeutix, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.97
$6.00
-13.91%
Oct 2026
$7.63
$6.97
-9.24%
Sep 2026
$10.56
$7.68
-28.88%
Aug 2026
$8.31
$10.80
+32.58%
Jul 2026
$9.96
$8.15
-16.92%
Jun 2026
$8.85
$9.81
+8.58%
May 2026
$9.32
$9.04
-3.47%
Apr 2026
$8.64
$9.36
+10.38%
Mar 2026
$8.72
$8.48
-5.15%
Feb 2026
$9.16
$8.94
-2.08%
Jan 2026
$12.12
$9.13
-24.73%
Dec 2025
$11.93
$12.13
-0.12%

OCUL Share Price FAQs